- Lobbying
- Lobbying by Fabiani & Company on behalf of 3-V Biosciences
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Danielle Organ Peters | n/a |
Danielle Organ Peters | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Research and development of pharmaceutical platform for biodefense.
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate